Feb 02, 2020 11:07 AM IST
The 30-share BSE Sensex plummeted by 1,877.66 points to close below the key 40,000-mark at 39,735.53 last week.
- Feb 01, 2020 11:06 AM IST
In terms of index contribution, HUL, ITC, Godrej Corp, Emami, Colgate and GlaxoSmithKline Consumer Healthcare were at the top.
- Feb 01, 2020 10:28 AM IST
The company's shares slipped even though the company's numbers were in line with expectations.
- Jan 31, 2020 07:55 PM IST
As a part of continuous market development initiatives to improve liquidity in debt market, the NSE said it is introducing RFQ platform, an electronic platform where market participants can negotiate their deals in any of the eligible securities.
- Jan 31, 2020 12:15 PM IST
The stock got traction after the company's December quarter numbers showed decent growth despite the slowdown in the economy.
- Jan 31, 2020 11:58 AM IST
The stock continues to be under pressure as the company's December quarter earnings failed to impress the market.
- Jan 30, 2020 02:21 PM IST
Total income rose to Rs 94.54 crore in the third quarter of 2019-20 fiscal, from Rs 77.83 crore in the corresponding period of the previous financial year.
- Jan 30, 2020 12:52 PM IST
However, the consolidated income of the company increased to Rs 744.66 crore in the October-December period, as against Rs 579.54 crore a year ago.
- Jan 30, 2020 12:05 PM IST
The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues.
- Jan 29, 2020 02:40 PM IST
Total income of the company rose to Rs 3,395.34 crore, from Rs 2,954.13 crore in the same period a year ago, Cholamandalam Financial Holdings said in a statement.
- Jan 29, 2020 02:10 PM IST
BSE will shift as many as 30 stocks, including McDowell Holdings, Emami Realty, United Van Der Horst, Hindustan Everest Tools, Technofab Engineering and Lactose India, to the trade-for-trade segment represented by T or XT groups.
- Jan 28, 2020 12:24 PM IST
The company had posted net profit (after tax) of Rs 59.7 crore in the year-ago period, Wabco India said in a filing to BSE.
- Jan 28, 2020 10:33 AM IST
"Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Azithromycin Tablets USP, 600 mg," the drug firm said in a filing to BSE.
- Jan 28, 2020 10:31 AM IST
"Following the inspection by the United States Food and Drug Administration (USFDA) at the lnvagen (US) manufacturing facility from December 2, 2019 to December 6, 2019, the company has received the establishment inspection report (EIR), indicating closure of the inspection," Cipla said in a filing to BSE.
- Jan 27, 2020 04:12 PM IST
The BSE Healthcare index emerged as the lone sectoral index that ended positive with a gain of 1.43%
- Jan 27, 2020 03:43 PM IST
The plea was filed by the Consumer Rights Foundation, which says DoT’s latest directions amount to contempt of court.
- Jan 27, 2020 01:04 PM IST
Haridwar-based Patanjali group, which has acquired debt-ridden Ruchi Soya, is expecting Rs 25,000 crore turnover this fiscal.
- Jan 24, 2020 11:58 AM IST
The stock logged a gain of 6.5 percent on January 23 after SBI chairman said the private lender was too big to be allowed to fail.
- Jan 24, 2020 11:40 AM IST
In a regulatory filing, the company said "its step-down wholly owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for triamcinolone acetonide ointment USP, 0.05 percent from the United States Food & Drug Administration (USFDA)".
- Jan 24, 2020 11:04 AM IST
"Alembic Pharmaceuticals Ltd (Alembic) today announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Bosentan tablets, 62.5 mg and 125 mg," the firm said in a BSE filing.
- Jan 23, 2020 08:42 PM IST
The exchange will introduce futures contracts on aluminium and zinc in commodity derivatives segment with effect from January 27, 2020, it said in a circular.
- Jan 23, 2020 12:19 PM IST
Domestic brokerage firm Sharekhan by BNP Paribas has maintained a positive view on the stock with an upside potential of 12-15 percent.
- Jan 23, 2020 12:07 PM IST
"Alembic Pharmaceuticals Limited (Alembic)...has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fenofibrate Tablets USP, 54 mg and 160 mg.
- Jan 23, 2020 11:55 AM IST
The proceeds will be used to meet long-term working capital requirements, refinance existing debt, general corporate purpose and ongoing capital expenditure, the Sajjan Jindal-led company said in a filing to BSE.
- Jan 23, 2020 10:27 AM IST
This will be the second Budget that will be presented by FM Nirmala Sitharaman, and is expected to provide key measures to boost the economy amid a slowdown